Pfizer sees emergency use filing for COVID-19 vaccine after US election - KSL.com

KSL

Pfizer Inc said on Friday it may file for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, making it unlikely a vaccine will be available before U.S. elections as President Donald Trump has promised. https://www.ksl.com/article/50032279/pfizer-sees-emergency-use-filing-for-covid-19-vaccine-after-us-election